Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Chen, Q; Yang, B; Nass, N; Schatz, C; Haybaeck, J.
Impact of Eukaryotic Translation Initiation Factors on Breast Cancer: Still Much to Investigate.
Cancers (Basel). 2020; 12(7):
Doi: 10.3390/cancers12071984
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Haybäck Johannes
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Breast carcinoma (BC) remains one of the most serious health problems. It is a heterogeneous entity, and mainly classified according to receptor status for estrogen (ER), progesterone (PR) and egf (HER2/Neu), as well as the proliferation marker ki67. Gene expression in eukaryotes is regulated at the level of both gene transcription and translation, where eukaryotic initiation factors (eIFs) are key regulators of protein biosynthesis. Aberrant translation results in an altered cellular proteome, and this clearly effects cell growth supporting tumorigenesis. The relationship between various eIFs and BC entities, as well as the related regulatory mechanisms, has meanwhile become a focus of scientific interest. Here, we give an overview on the current research state of eIF function, focusing on BC.
- Find related publications in this database (Keywords)
-
eukaryotic initiation factors
-
translation initiation
-
breast carcinoma